The FDA-approved Natural Product Dihydroergocristine Reduces the Production of the Alzheimer’s Disease Amyloid-Β Peptides
Scientific Reports - United Kingdom
doi 10.1038/srep16541
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 16, 2015
Authors
Publisher
Springer Science and Business Media LLC